COSCIENS Biopharma (CSCI) Short Term Debt

Annual Short Term Debt

$298.70 K
+$25.70 K+9.41%

December 1, 2023


Summary


Performance

CSCI Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIbalance sheetmetrics:

Quarterly Short Term Debt

$405.00 K
-$2000.00-0.49%

September 1, 2024


Summary


Performance

CSCI Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

CSCI Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.4%+35.6%
3 y3 years+18.0%+35.6%
5 y5 years-0.7%+35.6%

CSCI Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+31.3%-0.5%+78.0%
5 y5-year-13.3%+31.3%-0.5%+78.0%
alltimeall time-88.6%+482.3%-85.3%+2369.5%

COSCIENS Biopharma Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$405.00 K(-0.5%)
Jun 2024
-
$407.00 K(+37.0%)
Mar 2024
-
$297.00 K(-0.6%)
Dec 2023
$298.70 K(+9.4%)
$298.70 K(+3.8%)
Sep 2023
-
$287.80 K(-1.3%)
Jun 2023
-
$291.50 K(+3.4%)
Mar 2023
-
$282.00 K(+3.3%)
Dec 2022
$273.00 K(+20.0%)
$273.00 K(+19.2%)
Sep 2022
-
$229.10 K(-2.7%)
Jun 2022
-
$235.40 K(+0.1%)
Mar 2022
-
$235.10 K(+3.3%)
Dec 2021
$227.50 K(-10.2%)
$227.50 K(-21.0%)
Sep 2021
-
$288.10 K(-1.1%)
Jun 2021
-
$291.20 K(+9.6%)
Mar 2021
-
$265.60 K(+4.9%)
Dec 2020
$253.20 K(-26.5%)
$253.20 K(-5.0%)
Sep 2020
-
$266.40 K(-0.4%)
Jun 2020
-
$267.60 K(-7.0%)
Mar 2020
-
$287.80 K(-16.4%)
Dec 2019
$344.40 K(+14.5%)
$344.40 K(-9.6%)
Sep 2019
-
$381.10 K(-5.5%)
Jun 2019
-
$403.10 K(-2.3%)
Mar 2019
-
$412.50 K(+37.1%)
Dec 2018
$300.90 K(-59.5%)
$300.90 K(-33.1%)
Sep 2018
-
$449.90 K(-20.7%)
Jun 2018
-
$567.10 K(-17.3%)
Mar 2018
-
$686.10 K(-7.6%)
Dec 2017
$742.60 K(-6.9%)
$742.60 K(-6.3%)
Sep 2017
-
$792.20 K(-14.9%)
Jun 2017
-
$930.70 K(+17.6%)
Mar 2017
-
$791.30 K(-1.1%)
Dec 2016
$797.50 K(-42.6%)
$799.90 K(-48.0%)
Sep 2016
-
$1.54 M(+0.5%)
Jun 2016
-
$1.53 M(+1.6%)
Mar 2016
-
$1.51 M(+8.4%)
Dec 2015
$1.39 M(+91.9%)
$1.39 M(+77.0%)
Sep 2015
-
$785.80 K(-0.2%)
Jun 2015
-
$787.30 K(+13.7%)
Mar 2015
-
$692.60 K(-4.4%)
Dec 2014
$724.70 K(+34.8%)
$724.70 K(-2.9%)
Sep 2014
-
$746.00 K(-1.2%)
Jun 2014
-
$754.70 K(+21.5%)
Mar 2014
-
$621.40 K(+15.5%)
Dec 2013
$537.80 K(+217.3%)
$537.80 K(+219.0%)
Sep 2013
-
$168.60 K(+2.9%)
Jun 2013
-
$163.80 K(-2.4%)
Mar 2013
-
$167.80 K(-1.0%)
Dec 2012
$169.50 K(+12.0%)
$169.50 K(-82.7%)
Sep 2012
-
$981.40 K(-0.7%)
Jun 2012
-
$987.90 K(-5.5%)
Mar 2012
-
$1.05 M(+591.0%)
Dec 2011
$151.30 K(-75.4%)
$151.30 K(-75.6%)
Sep 2011
-
$619.90 K(-4.9%)
Jun 2011
-
$651.70 K(+1.6%)
Mar 2011
-
$641.40 K(+4.5%)
DateAnnualQuarterly
Dec 2010
$613.80 K(+366.1%)
$613.80 K(+377.3%)
Sep 2010
-
$128.60 K(-4.9%)
Jun 2010
-
$135.20 K(-2.0%)
Mar 2010
-
$138.00 K(+4.1%)
Dec 2009
$131.70 K(-49.1%)
$132.60 K(-4.3%)
Sep 2009
-
$138.50 K(+19.0%)
Jun 2009
-
$116.40 K(+10.2%)
Mar 2009
-
$105.60 K(-59.7%)
Dec 2008
$258.60 K(+129.1%)
$261.80 K(+113.5%)
Sep 2008
-
$122.60 K(-2.6%)
Jun 2008
-
$125.90 K(+16.8%)
Mar 2008
-
$107.80 K(-5.2%)
Dec 2007
$112.90 K(+80.6%)
$113.70 K(+42.1%)
Sep 2007
-
$80.00 K(-2.4%)
Jun 2007
-
$82.00 K(+53.0%)
Mar 2007
-
$53.60 K(-14.4%)
Dec 2006
$62.50 K(-36.9%)
$62.60 K(-57.2%)
Sep 2006
-
$146.20 K(+72.6%)
Jun 2006
-
$84.70 K(-3.1%)
Mar 2006
-
$87.40 K(-11.8%)
Dec 2005
$99.00 K(-29.2%)
$99.10 K(-7.9%)
Sep 2005
-
$107.60 K(-2.1%)
Jun 2005
-
$109.90 K(-17.6%)
Mar 2005
-
$133.40 K(-4.6%)
Dec 2004
$139.80 K(-13.2%)
$139.80 K(-5.3%)
Sep 2004
-
$147.60 K(+120.6%)
Jun 2004
-
$66.90 K(+8.4%)
Mar 2004
-
$61.70 K(-61.7%)
Dec 2003
$161.00 K(+50.7%)
$161.30 K(+112.8%)
Sep 2003
-
$75.80 K(-11.9%)
Jun 2003
-
$86.00 K(-9.2%)
Mar 2003
-
$94.70 K(-11.6%)
Dec 2002
$106.80 K(+108.2%)
$107.10 K(+100.9%)
Sep 2002
-
$53.30 K(-3.4%)
Jun 2002
-
$55.20 K(+6.2%)
Mar 2002
-
$52.00 K(+1.0%)
Dec 2001
$51.30 K(-76.4%)
$51.50 K(-2.8%)
Sep 2001
-
$53.00 K(-3.3%)
Jun 2001
-
$54.80 K(+8.1%)
Mar 2001
-
$50.70 K(-76.7%)
Dec 2000
$217.00 K(-36.9%)
$217.20 K(+1224.4%)
Sep 2000
-
$16.40 K(-97.0%)
Jun 2000
-
$540.10 K(+292.2%)
Mar 2000
-
$137.70 K(-60.1%)
Dec 1999
$343.90 K(+77.5%)
$345.20 K(+69.0%)
Sep 1999
-
$204.30 K(+54.2%)
Mar 1999
-
$132.50 K(-32.1%)
Dec 1998
$193.80 K(-74.7%)
$195.00 K(-25.6%)
Sep 1998
-
$262.00 K(-35.8%)
Jun 1998
-
$408.40 K(+16.0%)
Mar 1998
-
$352.20 K(-54.2%)
Dec 1997
$767.50 K(-70.8%)
$768.70 K(-72.1%)
Sep 1997
-
$2.75 M(+18.7%)
Jun 1997
-
$2.32 M(-5.9%)
Mar 1997
-
$2.46 M
Dec 1996
$2.63 M
-

FAQ

  • What is COSCIENS Biopharma annual short term debt?
  • What is the all time high annual short term debt for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual short term debt year-on-year change?
  • What is COSCIENS Biopharma quarterly short term debt?
  • What is the all time high quarterly short term debt for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly short term debt year-on-year change?

What is COSCIENS Biopharma annual short term debt?

The current annual short term debt of CSCI is $298.70 K

What is the all time high annual short term debt for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual short term debt is $2.63 M

What is COSCIENS Biopharma annual short term debt year-on-year change?

Over the past year, CSCI annual short term debt has changed by +$25.70 K (+9.41%)

What is COSCIENS Biopharma quarterly short term debt?

The current quarterly short term debt of CSCI is $405.00 K

What is the all time high quarterly short term debt for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly short term debt is $2.75 M

What is COSCIENS Biopharma quarterly short term debt year-on-year change?

Over the past year, CSCI quarterly short term debt has changed by +$106.30 K (+35.59%)